MG
Mark C. Genovese
Elite in Psoriatic Arthritis
Check Dr. Mark C. Genovese's experience treating your condition:
About Dr. Mark C. Genovese

Mark Genovese is a Rheumatologist in Redwood City, California. Genovese has been practicing medicine for over 31 years and is rated as an Elite expert by MediFind in the treatment of Psoriatic Arthritis. He is also highly rated in 10 other conditions, according to our data. His top areas of expertise are Rheumatoid Arthritis (RA), Arthritis, Psoriatic Arthritis, and Psoriasis. He is licensed to treat patients in California. Genovese is currently accepting new patients.

His clinical research consists of co-authoring 164 peer reviewed articles and participating in 13 clinical trials in the past 15 years. In particular, he has co-authored 15 articles and participated in 1 clinical trial in the study of Psoriatic Arthritis.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Mark C. Genovese it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
Locations
450 Broadway St, Redwood City, CA 94063
Other Locations
900 Blake Wilbur Dr, Palo Alto, CA 94304
Background & Education
Graduate Institution
Johns Hopkins University School Of Medicine, 1992
Specialties
Rheumatology
Licenses
Internal Medicine in CA
Hospital Affiliations
Stanford Hospital
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


13 Clinical Trials

A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Phase II, Single-Site, Double-Blind, Placebo-Controlled Randomized Withdrawal Study Assessing the Efficacy and Safety of Sarilumab in Patients With Glucocorticoid-Dependent Sarcoidosis
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA
A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis
A Pilot Trial of Adalimumab for the Treatment of Osteoarthritis
View 12 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Elite
Elite
Distinguished